HPV test for vaginal sampling or self-sampling

Back to the list
Eurofins Biomnis code

HPVPV

Synonyms
  • Vaginal sampling and self-sampling
Specialty

Infectious

Clinical significance

With 3,000 new cases of detected invasive cervical cancer (UCC) and 1,100 deaths each year, this cancer is one of the only cancers with a deteriorating prognosis. Following the recommendations of the HAS issued in July 2019, the decree published on March 25, 2020, applicable on April 1, 2020, modified and expanded the reimbursement modalities for HPV testing in the context of UCC screening by recommending, in particular, the performance of an HPV-HR test in primary screening in women aged 30 to 65 years old on a cervical sample. Nevertheless, a certain number of women do not undergo this traditional gynecological follow-up with cervico-uterine sampling for multiple reasons of acceptability and practicality. It is in this context that the HAS recommended the use of vaginal self-sampling. This HPV test on vaginal self-sampling is an alternative to cervical sampling by a health professional. The FLOQSwabs® self-sampling device that we provide to women is validated for HPV-HR testing with the BD Onclarity HPV test on the BD COR automated system. Practical and very easy to use, it consists of a dry swab to be recapped once the sample is taken. Storage and transport are done at room temperature. This kit is available from city biology laboratories that request it and wish to support us in this screening of as many women as possible. The sample can then be taken by the patient at home and brought to the laboratory, or taken directly to the laboratory (by the patient or the biologist). According to studies, the performance is equivalent between a self-collected HPV sample and one taken by a health professional

Preanalytics
  • A tube specifically for this analysis : No
Further information

Use the specific request form B63 : HPV test on vaginal swab or self-sampling (FLOQSwabs® Copam supplied by us).
Recap the swab after vaginal sampling and do not discharge it into a transport medium. The dry swab should be transported.
If the result is positive, the patient should have a cervical cytology performed by her health professional on a new endocervical-exocervical sample

Specific equipment available
  • K63P : Vaginal swab for sampling or self-sampling for cervical cancer screening.FLOQSwabs® Copan swab supplied by us
Documents to download
Methodology

Real-time PCR

Turnaround time

1 day

Testing Laboratory

Contact(s)
Customer Care